Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

67°
- Benton, AR (72018)
  Today
  
  Rain. High 66F. Winds WNW at 10 to 20 mph. Chance of rain 80%..
  
  Tonight
  
  Cloudy early, becoming mostly clear after midnight. Low 38F. Winds N at 10 to 20 mph.
  
  Updated: March 11, 2026 @ 1:54 pm
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2025
Community Calendar

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Centessa Pharmaceuticals plc - American Depositary Shares (NQ:CNTA)

28.36 +0.77 (+2.81%)

Streaming Delayed Price Updated: 3:30 PM EDT, Mar 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Centessa Pharmaceuticals plc - American Depositary Shares

< Previous 1 2 3 4 Next >

Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares

April 23, 2024

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024

April 22, 2024

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023

March 28, 2024

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference

February 22, 2024

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals to Present Additional 52-Weeks of Continuous Treatment Data from Third Year (Part 5) of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia at the 17th Annual Congress of the European Association for Haemophilia and

February 09, 2024

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

January 22, 2024

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals to Present at the 42ⁿᵈ Annual J.P. Morgan Healthcare Conference

December 13, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces New Data from an Additional 52-Weeks of Continuous Treatment from Third Year (Part 5) of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia

December 10, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Anaptys Expands Immune Cell Modulator Pipeline with Exclusive License to BDCA2 Modulator Antibody Portfolio from Centessa Pharmaceuticals

November 27, 2023

From AnaptysBio, Inc.

Via GlobeNewswire

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2023

November 13, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals to Present Additional 52-Weeks of Continuous Treatment Data from Third Year of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia at American Society of Hematology (ASH) Annual Meeting

November 02, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces Dosing of First Subject in Registrational PRESent-3 Study Evaluating SerpinPC for the Treatment of Hemophilia B with Inhibitors

October 31, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

October 30, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces Preclinical Data Supporting ORX750’s Potential as a Best-in-Class Oral OX2R Agonist for the Treatment of Narcolepsy and Other Sleep-Wake Disorders

October 25, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces Additions to Senior Leadership Team

October 03, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

August 31, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals to Present Preclinical Data for Novel Orexin Receptor 2 (OX2R) Agonist at World Sleep Congress

August 23, 2023

Oral presentation to include preclinical profile for ORX750, Centessa’s first orexin agonist development candidate for the treatment of narcolepsy and other sleep disorders

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2023

August 14, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces Dosing of First Subject in Registrational PRESent-2 Study Evaluating SerpinPC for the Treatment of Hemophilia B without Inhibitors

July 10, 2023

Enrollment progressing toward interim analysis planned when 36 subjects reach 12 weeks on treatment in Part 1 of study

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

May 24, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Receives Fast Track Designation from the U.S. FDA for SerpinPC for Hemophilia B

May 22, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2023

May 12, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Reports Recent Business Progress and Financial Results for the Fourth Quarter and Full-Year 2022

March 30, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

March 27, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces Addition of Patrick Yue, MD, as Senior Vice President of Clinical Development, Innovative Medicines

March 01, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Plc (NASDAQ:CNTA) Long Term Shareholder Notice: Investigation of Potential Wrongdoing ↗

February 14, 2023

San Diego, CA -- (SBWIRE) -- 02/14/2023 -- An investigation was announced for investors in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA) concerning potential breaches of fiduciary duties by...

Via SBWire

Centessa Pharmaceuticals to Present Additional Data from Open-Label Extension (OLE) of Phase 2a Study of SerpinPC for Hemophilia at the 16th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)

February 06, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces Presentation at the SVB Securities Global Biopharma Conference

February 02, 2023

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of LB101, First LockBody® Candidate, for Solid Tumors

January 26, 2023

LB101 is a conditionally tetravalent PD-L1xCD47 LockBody bispecific monoclonal antibody being developed for solid tumors

From Centessa Pharmaceuticals plc

Via GlobeNewswire

Centessa Pharmaceuticals Announces Additional 18-Months of Continued Treatment Data from Open-Label Extension (OLE) of Phase 2a Study of SerpinPC for Hemophilia

December 10, 2022

From Centessa Pharmaceuticals plc

Via GlobeNewswire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

Centessa Pharmaceuticals plc - American Depositary Shares (NQ:CNTA)

Press Releases about Centessa Pharmaceuticals plc - American Depositary Shares

Sections

Services

Follow Us